Showing results (1941-1950 of 2,738) with videos related to
Sort By:
Pageof 274
The Journal of Urology|March 9, 2018
Multiple Regions of Interest on Multiparametric Magnetic Resonance Imaging are Not Associated with Increased Detection of Clinically Significant Prostate Cancer on Fusion BiopsyNeal Patel, Joshua A Halpern, Khushabu Kasabwala, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2001
MCF-10A-NeoST: a new cell system for studying cell-ECM and cell-cell interactions in breast cancerN D Zantek, J Walker-Daniels, J Stewart, et al.Optics Express|October 10, 2013
High quality factor silica microspheres functionalized with self-assembled nanomaterialsIshac Kandas, Baigang Zhang, Chalongrat Daengngam, et al.Journal of Proteomics|December 3, 2014
Discovery by proteogenomics and characterization of an RF-amide neuropeptide from cone snail venomSamuel D Robinson, Helena Safavi-Hemami, Shrinivasan Raghuraman, et al.ERJ Open Research|February 3, 2021
Controlled versus free breathing for multiple breath nitrogen washout in healthy adultsBlake M Handley, Edward Jeagal, Robin E Schoeffel, et al.Acta Neuropathologica Communications|May 10, 2019
LMTK2 binds to kinesin light chains to mediate anterograde axonal transport of cdk5/p35 and LMTK2 levels are reduced in Alzheimer's disease brainsGábor M Mórotz, Elizabeth B Glennon, Patricia Gomez-Suaga, et al.Cancer Discovery|January 22, 2014
RapidCaP, a novel GEM model for metastatic prostate cancer analysis and therapy, reveals myc as a driver of Pten-mutant metastasisHyejin Cho, Tali Herzka, Wu Zheng, et al.Cancers|April 5, 2020
Validation of an Automated Quantitative Digital Pathology Approach for Scoring TMEM, a Prognostic Biomarker for MetastasisDavid Entenberg, Maja H Oktay, Timothy D'Alfonso, et al.Astrobiology|April 21, 2018
Exoplanet Biosignatures: A Framework for Their AssessmentDavid C Catling, Joshua Krissansen-Totton, Nancy Y Kiang, et al.The Journal of Pathology|April 18, 2019
Intraductal carcinoma of the prostate in the absence of high-grade invasive carcinoma represents a molecularly distinct type of in situ carcinoma enriched with oncogenic driver mutationsFrancesca Khani, Sara E Wobker, Jessica L Hicks, et al.Pageof 274